Questions about Residual Cell Viability in Cryopreserved Human Amniotic Membrane and Its Impact on Clinical Applications

Biomedicines. 2022 Oct 1;10(10):2456. doi: 10.3390/biomedicines10102456.

Abstract

We questioned the relevance of evaluating residual cell viability in human amniotic membrane (hAM) after its cryopreservation since cell survival is controversial and its ability to act as a matrix (including the presence of growth factors and cytokines) appears to be most important for tissue regeneration purposes. We also discussed the usefulness of osteodifferentiating amniotic cells in whole hAM for bone repair applications. We have evidence that determining residual cell viability after cryopreservation and hAM osteodifferentiation is not justified.

Keywords: amniotic membrane; cell survival; cryocongelation; cryopreservation; differentiation; matrix; quality controls; viability.

Grants and funding

This research received no external funding.